Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 CAD | +24.00% | +24.00% | +34.78% |
29/03 | Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
28/02 | Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01/86/01 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29/10/29 |
Guy-Paul Allard
LAW | General Counsel | 56 | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Tinmouth
BRD | Director/Board Member | - | 28/04/28 |
Steven Saviuk
CEO | Chief Executive Officer | 65 | 01/86/01 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 29/10/29 |
Marc Bélair
BRD | Director/Board Member | - | 03/20/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,661,276 | 4,880,389 ( 38.55 %) | 0 | 38.55 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
VALEO PHARMA INC. 25.72% | 25,372,987 | 25.72% | 1,649,244 $ |
CHITOGENX INC. 10.34% | 5,275,392 | 10.34% | 242,668 $ |
Company contact information
Manitex Capital, Inc.
16667 Hymus Boulevard
H9H 4R9, Kirkland
+
Sector
1st Jan change | Capi. | |
---|---|---|
+34.78% | 2.85M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- MNX Stock
- Company Manitex Capital Inc.